Paper Details

  1. Home
  2. Paper Details

[Laboratory and clinical studies on cefprozil in the field of pediatrics].

Author: AndoH, AndoY, HayakawaF, KunoK, NakaoY, OgawaA

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Cefprozil (CFPZ) demonstrated superior antibacterial activity against Gram-positive cocci compared to cefaclor and against E. coli compared to ampicillin. In pediatric patients with acute infections, CFPZ achieved a 100% clinical efficacy rate and 56% bacteriological efficacy rate with minimal side effects.
Paper Details　
Original Abstract of the Article :
Laboratory and clinical studies on cefprozil (CFPZ, BMY-28100), a new cephem antibiotic, were carried out in the field of pediatrics. The results obtained are summarized as follows: 1. Serum concentrations, urinary concentrations and urinary recovery rates of CFPZ were determined upon oral administr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1494237

データ提供：米国国立医学図書館（NLM）

Cefprozil: A New Cephem Antibiotic for Pediatric Infections

Pediatric infections can be a daunting challenge for both clinicians and their young patients. This study investigates the efficacy and safety of cefprozil, a new cephem antibiotic, in treating a variety of pediatric infections. It's like discovering a new source of water in a parched desert, offering a potential solution to a critical problem.

A New Weapon in the Fight Against Pediatric Infections

The study demonstrates that cefprozil is effective in treating a range of pediatric infections, including pharyngitis, bronchitis, pneumonia, and skin infections. The researchers found that cefprozil was well-tolerated, with minimal side effects. It's like finding a reliable camel to carry essential supplies across a vast and unforgiving desert.

Cefprozil: A Beacon of Hope

This research offers a valuable new tool for pediatricians treating a variety of infections. Cefprozil, with its efficacy and safety profile, provides a hopeful solution for children battling these infections. It's like discovering a hidden oasis, offering relief and rejuvenation to those in need.

Dr.Camel's Conclusion

This study provides encouraging evidence for the efficacy and safety of cefprozil in treating pediatric infections. It represents a significant advance in our arsenal against these common ailments, offering a potential solution for children facing these challenges. Just as a camel navigates the desert landscape, we must always seek new ways to conquer the obstacles we face in medicine.

Date :
  1. Date Completed 1993-03-11
  2. Date Revised 2023-12-13
Further Info :

Pubmed ID

1494237

DOI: Digital Object Identifier

1494237

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.